Clinical Trials
Find Clinical Trials by State:
NIMH: Autism Spectrum Disorder and Obsessive Compulsive Disorder Study
If your child or teen (ages 7-17) is suffering from Obsessive-Compulsive Disorder (OCD) he or she may be able to participate in a research study at the National Institute of Mental Health (NIMH). We are investigating the medication riluzole.
Children and adolescents with 1) both Autism Spectrum Disorder and OCD or 2) a primary diagnosis of OCD may be eligible. Participants will be randomized to either riluzole or placebo (pill with no active ingredient) for 12 weeks. At the end of 12 weeks, all participants will have the option of taking riluzole (no chance of placebo). A comprehensive psychiatric and medical evaluation and follow-up visits approximately monthly for 6 months, and at 9 and 12 months, are included. There is no cost to participate. Travel assistance may be provided.
For further information please call 301-435-6652 or 301-496-5323 (Lorraine Lougee, LCSW-C) or email OCDNIMH@intra.nimh.nih.gov .
National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services.
For more Clinical Research Information: http://patientinfo.nimh.nih.gov